Recursion Pharmaceuticals Reports Positive Phase 1b/2 TUPELO Trial Results, Validating AI-Driven Therapy for FAP

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion ...

Recursion Pharmaceuticals Rises as Positive Phase 1b/2 Trial Results for REC-4881 Validate AI-Driven Drug Discovery Platform

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...
Le Lézard

Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases

Aurora Therapeutics today announced its official launch to transform personalized gene editing from a one-patient breakthrough into a scalable model capable of bringing therapies to millions of ...
InfoWorld

Back to the future: The most popular JavaScript stories and themes of 2025

The key themes that defined the year behind us will also shape the one ahead. The most-read articles of 2025 tracked a return ...

Ask An SEO: Can AI Systems & LLMs Render JavaScript To Read ‘Hidden’ Content?

What are the differences between how AI systems handle JavaScript-rendered or interactively hidden content compared to ...

In Hearing Transcript, Jack Smith Defends Decision to Indict Trump

The former special counsel accused President Trump of “exploiting” violence on Jan. 6, 2021, according to an interview ...
Scientific Research Publishing

Opportunism in Supply Chain Recommendations: A Dynamic Optimization Approach ()

Fruchter, G. (2026) Opportunism in Supply Chain Recommendations: A Dynamic Optimization Approach. Modern Economy, 17, 26-38.